Delivering Insulin via Oral Delivery, Transdermal Patches and Inhalers

In spite of – and perhaps because of - the collapse of the inhaled insulin market in 2008, programs focused on alternative insulin delivery technologies continue to move forward. All of these numerous development-stage programs share the common goal of reaping commercial success by creating patient-friendly insulin delivery methods that address the preference and compliance issues associated with traditional injection methods. The market for insulin will grow significantly as the rate of increase in the number of patients diagnosed with both Type I and Type II diabetes grows worldwide. Over the next six years, injection and other parenteral insulin delivery products will have to compete with emerging insulin delivery methods – methods that will include pulmonary, intranasal, transdermal and oral insulin delivery. Each of these alternative delivery methods will be competing to take market share away from traditional insulin delivery methods, which will come under escalating pressure as new delivery systems are approved and commercialized.

Publication Date: January 2010

Table of Contents

Text Box: Table of Contents

Executive Summary

The Market Dynamics of Insulin Delivery

Diabetes Economics

Glucose Monitoring and Glycemic Control

Key Factors in Patient Compliance

Insulin Demand Factors

Delivery Technology and Usage Trends

Delivering Insulin – Commercial Devices

Disposable Syringes

Dosing Accuracy and Safety

Demand for Auto Injectors

Universal Autoinjectors

Branded Autoinjectors

Pen Injectors

Reusable Pens and Insulin Cartridges

Prefilled Disposable Pens

Branding and Patient-friendly Features

Needle-free injectors

Technology and Patient Options

Demand Picture

Insulin Pumps

Pump Designs

Wireless and Data Management

Closed Loop Systems

Development-stage Insulin Delivery Products

Modified Release Injectable Insulin

Inhaled Insulin

Pulmonary Insulin Delivery

Device Designs and Formulation Technology

Products, Players and Prospects

Intranasal Insulin Delivery

Product Technology

Risks and Prospects

Next-Gen Insulin Pumps

Disposable Pumps

Implantable Pumps

Oral Insulin

Oral Formulation Technology

Competing Oral Delivery Methods

Transdermal Insulin

Energy-assisted Systems

Microporation-based Systems

Transmucosal Insulin

Insulin Delivery – Market Factors

Regulatory Issues

Patient Preferences and Ease of Use

Healthcare Economics

Delivering Insulin - Company Profiles

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.